XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenues
 9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2022202120222021
JAKAFI revenues, net$619,595 $547,373 $1,761,732 $1,542,138 
ICLUSIG revenues, net25,929 28,522 78,222 82,356 
PEMAZYRE revenues, net23,414 17,562 60,429 48,924 
MINJUVI revenues, net5,932 556 14,845 556 
OPZELURA revenues, net38,140 — 67,454 — 
Total product revenues, net713,010 594,013 1,982,682 1,673,974 
JAKAVI product royalty revenues85,808 94,655 240,386 242,295 
OLUMIANT product royalty revenues20,371 86,572 98,689 154,875 
TABRECTA product royalty revenues4,114 2,747 11,178 7,270 
Total product royalty revenues110,293 183,974 350,253 404,440 
Milestone and contract revenues— 35,000 135,000 45,000 
Total revenues$823,303 $812,987 $2,467,935 $2,123,414 
For further information on our revenue-generating contracts, refer to Note 7.